What is the CNS prophylaxis when the hyper-CVAD regimen is used to treat Burkitt lymphoma/Burkitt-like lymphoma (BL/BLL)?

Updated: Dec 20, 2019
  • Author: Ali H Kanbar, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

See the list below:

  • Methotrexate intrathecally on day 2 of each cycle, 12 mg/dose via lumbar puncture or 6 mg/dose via Ommaya reservoir

  • Cytarabine 100 mg/dose intrathecally via lumbar puncture or Ommaya reservoir administered on day 7 for 8 cycles

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!